Cargando…

The Role of Pharmaceutical Companies in Antimicrobial Stewardship: A Case Study

Rising levels of antimicrobial resistance pose serious dangers to patients, population health, food security, and economic stability worldwide. In response to this threat, the United Nations and the World Health Organization have called for multisectoral, multidisciplinary action, recognizing that h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hermsen, Elizabeth D, Sibbel, Richard L, Holland, Silas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384317/ https://www.ncbi.nlm.nih.gov/pubmed/31970384 http://dx.doi.org/10.1093/cid/ciaa053

Ejemplares similares

What are the obligations of pharmaceutical companies in a global health emergency?
por: Emanuel, Ezekiel J, et al.
Publicado: (2021)

Sepsis and antimicrobial stewardship: two sides of the same coin
por: Fitzpatrick, Fidelma, et al.
Publicado: (2019)

A commitment and call to strengthen and expand qualitative research efforts to improve the impact of antimicrobial stewardship
por: van den Bergh, Dena, et al.
Publicado: (2021)

Introducing the global antimicrobial stewardship partnership hub (GASPH): creating conditions for successful global partnership collaboration
por: Sneddon, Jacqueline, et al.
Publicado: (2022)

Importance of non-pharmaceutical interventions in the COVID-19 vaccination era: A case study of the Seychelles
por: Vilches, Thomas N, et al.
Publicado: (2021)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

A stewardship approach to shaping the future of public health supply chain systems
por: Bornbusch, Alan, et al.
Publicado: (2014)

Ebola and the need for restructuring pharmaceutical incentives
por: Karan, Abraar, et al.
Publicado: (2015)

The Intersection of Antimicrobial Stewardship, the Pharmaceutical Industry, and the Federal Legislature
por: Gregory, Eric, et al.
Publicado: (2022)

Using the Delphi method to identify meaningful and feasible outcomes for pharmaceutical value-based contracting
por: Swart, Elizabeth C S, et al.
Publicado: (2020)

Loss of exclusivity of ceftazidime/avibactam in low- and middle-income countries: a test for antibiotic stewardship practice
por: Veeraraghavan, Balaji, et al.
Publicado: (2023)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatments
por: Sullivan, Sean D, et al.
Publicado: (2022)

Technology, Training, and Task Shifting at the World’s Largest Mass Gathering in 2025: An Opportunity for Antibiotic Stewardship in India
por: Chan, Isaac H Y, et al.
Publicado: (2023)

Unmet Medical Needs and the Role of Pharmaceutical Companies
por: Meyer-Sabellek, Wolfgang
Publicado: (2009)

The Role of the Private Sector in Advancing Antimicrobial Stewardship: Recommendations from the Global Chief Medical Officers' Network
por: Hermsen, Elizabeth D., et al.
Publicado: (2021)

E-pharmacies in India: Can they improve the pharmaceutical service delivery?
por: Satheesh, Gautam, et al.
Publicado: (2019)

Patient Influencers: The Next Frontier in Direct-to-Consumer Pharmaceutical Marketing
por: Willis, Erin, et al.
Publicado: (2022)

Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019
por: Wang, Yan, et al.
Publicado: (2020)

Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing
por: Jiang, Shan, et al.
Publicado: (2020)

Pharmaceutical industry, non-communicable diseases and partnerships: More questions than answers
por: Beran, David, et al.
Publicado: (2017)

Establishing Health Biotech and Enhancing Local Manufacturing of Pharmaceuticals in Sub-Saharan Africa
por: Balcha, Taye T
Publicado: (2018)

Upholding Human Rights in the Wake of COVID-19: Time to Strengthen Pharmaceutical Accountability
por: Turkie, Rosalind
Publicado: (2022)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Effectiveness assessment of non-pharmaceutical interventions: lessons learned from the COVID-19 pandemic
por: Lison, Adrian, et al.
Publicado: (2023)

Global access to existing and future antimicrobials and diagnostics: antimicrobial subscription and pooled procurement
por: Berman, Daniel, et al.
Publicado: (2022)

Decreasing the Peril of Antimicrobial Resistance Through Enhanced Health Literacy in Outpatient Settings: An Underrecognized Approach to Advance Antimicrobial Stewardship
por: Hermsen, Elizabeth D., et al.
Publicado: (2020)

Quality Criteria for Real-world Data in Pharmaceutical Research and Health Care Decision-making: Austrian Expert Consensus
por: Klimek, Peter, et al.
Publicado: (2022)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies
por: Smith, Richard
Publicado: (2005)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

A call to action—stopping antimicrobial resistance
por: Eisinger, Robert W, et al.
Publicado: (2023)

Hardwiring antimicrobial resistance mitigation into global policy
por: Thornber, Kelly, et al.
Publicado: (2022)

Antimicrobial resistance and over the counter use of drugs in Nepal
por: Pokharel, Sunil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_83djmu9b0sruiio4993mgdrklh